NSE filing, NSE: SENCO. Summary written from the filing by ALFA Finder's alert engine.
Senco Gold Ltd: key numbers
- Share price
- ₹306.25
- Market cap
- ₹5,019 Cr
- Revenue (annual)
- ₹8,430 Cr
- Net profit (annual)
- ₹574.3 Cr
- P/E (TTM)
- 8.8×Sector 49.0×
- Promoter holding
- 64.46%-0.01% QoQ
- FII holding
- 6.31%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Senco Gold Ltd
All →Senco Gold Acquisition Worth ₹68 Cr
Senco Gold signed agreements to acquire 68% of August Jewellery for INR 68 crore, payable in tranches. Completion is subject to conditions precedent, expected by February 2027.
- Value
- ₹68.00 Cr
Senco Gold Management Change
Senco Gold Ltd appointed Mr. Shashi Bhushan Singh as Chief General Manager – Sales and Business Development, designating him as a Senior Management Personnel.
Senco Gold Other Announcement
Senco Gold Limited submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026.
Senco Gold Business Update
Senco Gold's Q2 FY27 business update highlights 29% retail revenue growth and the opening of 6 new showrooms, bringing the H1 total to 14 additions.
- new showrooms opened
- 6.0 showrooms
Senco Gold Acquisition
Senco Gold has extended the expected completion timeline for its 68% acquisition of August Jewellery Private Limited (Melorra) to October 31, 2026, as documentation is still underway.
Senco Gold Merger & Restructuring
Senco Gold announced a delay in the acquisition of August Jewellery Private Limited (brand name Melorra). The transaction completion timeline is extended to 31st October 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.